We’re back with the fumble. Last week I was indisposed, apologies. A sexy nurse was slicing open my right arm and stuffing a camera through the artery all the…
Craig Amos
Looks like pot is the new crypto. In what can only be described as a wild day of trading, cannabis newcomer Tilray (TLRY.NASDAQ) traded within a 149 dollar range…
Hemp is hot and Elixinol Global (EXL.ASX) is riding the wave Hemp, the perennially uncool cousin of Mary Jane is staging something of a comeback. Often touted as an…
The publican of the Kambalda Hotel in the sleepy Western Australian town of the same name may need to order in a few extra slabs of beer this week….
A mini tech-wreck with FANG stocks trading at 3-week lows. Amazon (AMZN.NASDAQ) breaking the 2000 buck sound barrier. Are these things you should concern yourself with if you’re trading…
Muay Thai is the national sport here in my adopted homeland. Known as ‘the science of eight limbs‘ it’s a brutal contest – a knee or elbow to the…
I still remember what it felt like to wake up and realize it was Friday when I was entombed in a corporate cubicle. Everything was sweeter – even the…
It’s been a long ten months for CannPal Animal Therapeutics (CP1.ASX) shareholders having watched their investment hover around the $0.20 IPO issue price. While other ASX cannabis names have…
On the surface, the rights issue announced by Creso Pharma (CPH.ASX) looks to be a decent deal for long-suffering shareholders, albeit it a little unusual. The rights issue is…
The Australian government has really dropped the ball when it comes to easy access to medicinal cannabis. Want proof? Sometimes all you need is a picture, like the one…